Associated Papers
Mefatinib as first-line treatment of patients with advanced EGFR-mutant non-small-cell lung cancer: a phase Ib/II efficacy and biomarker study.
Wang P et al.
Signal Transduction and Targeted Therapy, 2021
34719670 (PubMed )
Supplement: 41392_2021_773_MOESM2_ESM.xlsx › NGS_report
Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology.
Morani F et al.
Frontiers in Neurology, 2020
33584503 (PubMed )
Supplement: Table_3.XLSX › B
Select a paper to view details